Fiera Capital (Canada)’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,783
Closed -$39.5K 497
2023
Q4
$39.5K Hold
1,783
﹤0.01% 506
2023
Q3
$38.5K Hold
1,783
﹤0.01% 489
2023
Q2
$120K Hold
1,783
﹤0.01% 490
2023
Q1
$832K Hold
1,783
﹤0.01% 370
2022
Q4
$714K Hold
1,783
﹤0.01% 392
2022
Q3
$580K Hold
1,783
﹤0.01% 457
2022
Q2
$471K Hold
1,783
﹤0.01% 510
2022
Q1
$536K Hold
1,783
﹤0.01% 514
2021
Q4
$629K Hold
1,783
﹤0.01% 480
2021
Q3
$456K Hold
1,783
﹤0.01% 469
2021
Q2
$1.19M Sell
1,783
-24,844
-93% -$14.3M ﹤0.01% 388
2021
Q1
$23.1M Sell
26,627
-281
-1% -$299K 0.07% 142
2020
Q4
$24.9M Sell
26,908
-13,966
-34% -$14.7M 0.07% 162
2020
Q3
$42M Buy
40,874
+13,254
+48% +$14.3M 0.12% 102
2020
Q2
$28M Sell
27,620
-660
-2% -$613K 0.09% 131
2020
Q1
$24.6M Sell
28,280
-472
-2% -$469K 0.1% 125
2019
Q4
$30.8M Sell
28,752
-1,173
-4% -$1.2M 0.1% 136
2019
Q3
$27.7M Sell
29,925
-678
-2% -$745K 0.1% 142
2019
Q2
$34.6M Buy
30,603
+5,462
+22% +$5.98M 0.13% 130
2019
Q1
$34.2M Buy
+25,141
New +$34.1M 0.13% 130
2018
Q4
Sell
-1,177
Closed -$1.79M 683
2018
Q3
$1.79M Sell
1,177
-1,061
-47% -$1.63M 0.01% 435
2018
Q2
$3.5M Sell
2,238
-101
-4% -$132K 0.02% 346
2018
Q1
$2.7M Sell
2,339
-195
-8% -$257K 0.01% 362
2017
Q4
$3M Sell
2,534
-520
-17% -$652K 0.01% 346
2017
Q3
$4.11M Buy
+3,054
New +$3.22M 0.02% 315
2017
Q2
Sell
-340
Closed -$209K 662
2017
Q1
$209K Buy
+340
New +$207K ﹤0.01% 607
2016
Q4
Sell
-416
Closed -$215K 775
2016
Q3
$215K Buy
+416
New +$196K ﹤0.01% 690

Other funds holding KYNB

Fiera Capital (Canada)'s KYNB Position: Q1 2024 in Review

Fiera Capital (Canada) sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 1,783 shares — an estimated $39.5K sold.

Fiera Capital (Canada) first reported a position in KYNB in Q3 2016 and held it in 27 quarters. The position peaked at $42M in Q3 2020. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Fiera Capital (Canada) reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,783 Kyntra Bio shares in Q1 2024, an estimated $39.5K.
  • Fiera Capital (Canada) first reported a position in Kyntra Bio in Q3 2016 and held it in 27 quarters.
  • Fiera Capital (Canada)'s Kyntra Bio position peaked at $42M in Q3 2020.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2024, filed 1 May 2024.